Skip to main content
. 2019 Aug 23;63(9):e00590-19. doi: 10.1128/AAC.00590-19

FIG 5.

FIG 5

The true status of recurrent infections on each day of follow-up for a simulated trial of DHA-PPQ with a true failure rate of 12% and an FOI of 8. The multiplicity of infection (MOI) is drawn from data from Tanzania—a relatively high-transmission area. The total height of the bars indicates the number of recurrent infections detected on that day of follow-up, and the color coding shows the number of those recurrent infections that were truly recrudescent or reinfections.